Drug Type Gene therapy, T-lymphocyte cell therapy |
Synonyms anti-KRAS G12D mTCR PBL, anti-KRAS-G12D-mTCR, Anti-mutated KRAS T-Cell receptors |
Target |
Action inhibitors |
Mechanism KRAS G12D inhibitors(GTPase KRas G12D inhibitors), Gene transference(Gene transference), T lymphocyte replacements |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingClinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Colorectal Cancer | Clinical | United States | - | - |
Colorectal Cancer | Clinical | - | - | |
Colorectal Cancer | Clinical | - | - |